Kidney injury is one of the most frequent and serious complications seen in intensive care units. When the kidneys are stressed or damaged, waste products, fluids, and electrolytes can build up quickly, affecting the heart, lungs, brain, and other organs. Because the kidneys can lose a great deal of function before obvious symptoms appear, doctors rely on careful monitoring, laboratory testing, and increasingly on substances called biomarkers to catch problems as early as possible.
In this article, you will learn what kidney biomarkers are, why they matter in the ICU, which ones are commonly used today, how they differ from traditional tests, and what their limitations are. You will also find a list of questions families can ask the care team to better understand what the numbers mean.
Why Kidney Injury Is a Major Concern in the ICU
The kidneys filter blood, remove waste, balance body fluids, control blood pressure, and help regulate electrolytes and red blood cell production. During critical illness, several forces can work against them at once:
- Low blood pressure or poor blood flow from sepsis, bleeding, heart failure, or shock
- Infections and inflammation that directly stress kidney tissue
- Medications, including some antibiotics, pain relievers, and blood pressure drugs
- Major surgery, especially heart and vascular procedures
- Imaging dyes used for certain scans
- Severe dehydration, fluid overload, or muscle breakdown
When acute kidney injury develops in the ICU, it is linked to longer hospital stays, a higher risk of needing dialysis, and a greater chance of long-term kidney problems after recovery. Catching injury early gives the care team more options for protecting the kidneys and adjusting treatment.
What Exactly Is a Biomarker?
A biomarker is a measurable substance in blood, urine, or tissue that reflects what is happening in the body. In kidney care, biomarkers generally fall into two broad categories:
- Markers of function, which show how well the kidneys are filtering
- Markers of injury, which show whether kidney cells are being damaged
A helpful way to picture the difference is a car dashboard. A function marker is like the speedometer, telling you how fast the engine is running right now. An injury marker is more like a warning light, signaling that something inside is being strained even before performance changes noticeably. Much of the recent progress in ICU kidney care involves injury markers that appear hours before function tests change.
The Traditional Standbys: Creatinine and Urine Output
Before discussing newer tests, it helps to understand the two measurements that remain the foundation of kidney monitoring in every ICU.
Serum creatinine
Creatinine is a waste product from normal muscle activity that healthy kidneys remove steadily. It is measured with a routine blood test. The challenge is that creatinine rises slowly. By the time it climbs above a person’s baseline, a meaningful amount of kidney function may already be lost. Creatinine levels are also affected by muscle mass, age, sex, hydration, diet, and certain medications, so a single number must always be compared with earlier results and the overall clinical picture.
Hourly urine output
In the ICU, urine is usually measured hour by hour through a catheter. A drop in urine production is one of the earliest and most sensitive signs that the kidneys are struggling. Urine output can be affected by diuretics, fluid status, and blockages in the urinary tract, so it is interpreted alongside other findings.
Other bedside clues
Additional traditional checks include urine microscopy, which can reveal signs of tubular damage, and calculations that compare sodium and creatinine levels in blood and urine to help distinguish dehydration-related changes from direct kidney injury.
Newer Biomarkers Being Used or Studied
Because creatinine and urine output lag behind actual damage, researchers have identified molecules released by injured kidney tubule cells or by the body in response to kidney stress. Some are now used in clinical practice, while others remain largely in research settings.
Cystatin C
Cystatin C is a protein produced by most cells and filtered by the kidneys. It is less dependent on muscle mass than creatinine, which makes it useful in people who are very muscular, very frail, or critically ill with muscle wasting. It can also help estimate kidney function when creatinine results are hard to interpret.
NGAL (neutrophil gelatinase-associated lipocalin)
NGAL is one of the most studied kidney biomarkers. It can be measured in blood or urine and tends to rise within a few hours of tubular injury, well before creatinine changes. It is produced in response to infection and inflammation as well, so elevated results must be interpreted carefully in patients with sepsis or other inflammatory conditions.
KIM-1 (kidney injury molecule-1)
KIM-1 appears on the surface of injured proximal tubule cells and can be detected in urine. Higher levels suggest ongoing tubular damage and have been linked with a slower recovery and a greater chance of lasting kidney problems.
TIMP-2 and IGFBP7
These two proteins are markers of cell cycle arrest, a protective response in which stressed cells pause their normal division. When measured together in urine, they help identify patients at high risk of moderate to severe kidney injury. This information is often used to guide decisions about avoiding additional kidney stressors, such as certain medications or contrast dyes, and to prompt closer monitoring.
Interleukin-18 and L-FABP
Interleukin-18 is an inflammation-related molecule that rises in urine after tubular injury. L-FABP, or liver-type fatty acid binding protein, reflects oxidative stress inside kidney tubules. Both have shown promise in research and select clinical settings, particularly for predicting worsening injury after surgery or in sepsis.
Proenkephalin and CCL14
Proenkephalin is a blood marker that tracks filtration more steadily than creatinine in critically ill patients. CCL14 is a urine marker that has been studied for its ability to predict which patients will recover kidney function and which are more likely to develop persistent injury requiring extended support, including dialysis.
How Biomarkers Are Used in ICU Care
Biomarkers are rarely used alone. They are tools that add detail to a broader assessment. Common roles include:
- Early detection: spotting injury before creatinine rises or urine output falls noticeably
- Risk assessment: identifying patients most likely to worsen, so monitoring can be intensified
- Clarifying the cause: helping distinguish reduced blood flow from direct kidney damage
- Guiding treatment: informing fluid management, medication choices, and timing of procedures
- Anticipating support needs: estimating the likelihood that dialysis may become necessary
- Monitoring trends: tracking whether injury is improving or progressing over hours and days
What Biomarkers Can and Cannot Tell You
It is important to understand their limits:
- No single biomarker is perfect. Each has strengths and blind spots, which is why several tests are often combined.
- Other conditions can raise levels. Infections, inflammation, and some chronic illnesses can elevate certain markers without new kidney damage.
- Timing matters. A test taken too early or too late may miss the window when it is most informative.
- Availability varies. Not every hospital offers every biomarker, and some remain limited to research or specialty centers.
- They do not replace clinical judgment. The care team interprets results alongside physical examination, vital signs, medication history, imaging, and the patient’s overall condition.
How Severity Is Described
Kidney injury in the ICU is usually graded using internationally agreed criteria that combine how much creatinine has risen, how long urine output has been low, and whether kidney replacement therapy such as dialysis is needed. Mild injury may only require close monitoring and adjustments to fluids and medications. Severe injury may require temporary dialysis while the kidneys recover, and some patients need ongoing kidney care after leaving the hospital.
Questions Families Can Ask the Care Team
- Which kidney tests are being followed, and how often are they repeated?
- Is this a problem with blood flow to the kidneys, direct damage to kidney tissue, or both?
- Are any medications or procedures being adjusted to protect the kidneys?
- Has the trend improved, stayed the same, or worsened over the past day?
- Is dialysis being considered, and what would prompt that decision?
- What follow-up testing will be recommended after discharge?
Protecting Kidney Health After Critical Illness
Recovery does not end at discharge. People who experience acute kidney injury in the ICU are at higher risk of future kidney problems, so follow-up matters. General steps that support kidney health include staying well hydrated unless a doctor advises otherwise, managing blood pressure and blood sugar, reviewing medications regularly with a clinician, avoiding unnecessary kidney-irritating pain relievers, and keeping scheduled lab appointments. Anyone with ongoing concerns about kidney function should discuss them with a qualified healthcare professional.
The Bottom Line
Biomarkers have changed how ICU teams think about kidney injury. Traditional measures such as creatinine and urine output remain essential, but newer markers can reveal kidney stress hours earlier, help predict which patients are most at risk, and guide treatment decisions. They are supportive tools rather than stand-alone answers, and they work best when combined with careful clinical assessment.
If you or a loved one is in intensive care, do not hesitate to ask questions about kidney monitoring and what the results mean for the plan of care. Understanding the basics can make an overwhelming situation a little easier to navigate. For more plain-language guidance on kidney health, critical care, and preventive medicine, explore the related articles available on our site.